Biolight Speed Up BP development

Biolight Speed Up BP development

Recently, Biolight Meditech Guandong Biolight Meditech Blood Purification subsidiary to accelerate the layout of the entire industry in the Blood Purification field To establish Technology Co., LTD. The registered capital is 100 million yuan. Since this year, biolite has owned shares in several companies through capital increases and mergers. This indicates that after years of testing and exploration, Biolight is moving to the next stage of acceleration in the blood purification field.

The company said that the biolite is working on building a complete industrial chain layout of blood purification. In order to survive the fierce competition, it is necessary to strengthen investment to make the blood purification business bigger and stronger, increase the resources and energy, and gradually increase the brand awareness in the blood purification field. .

In order for the biolite group to focus on the blood purification business, the establishment of a wholly owned subsidiary is considered to be an important measure. This can better guide and integrate the advantages of an enterprise's industrial chain, channel network, location layout, and scale. It will also focus resources and strengths to accelerate the blood purification business, improve the design of product innovation and the ability to manage and control the industrial chain, thereby strengthening the overall competitiveness and profit growth path.

In fact, Biolight has been deeply involved in the blood purification field for several years with in-house development and expanded mergers and acquisitions. This includes a comprehensive layout of dialysis machines, perfusion devices, water treatment systems, sterilization systems, concentrated fluid delivery systems, dialysis consumables, sales channels, hospital services and other blood purification ecosystems. Especially when it comes to sales channels, Biolight has three channel platform companies in China, and its products now cover nearly 5,000 hospitals in China and more than 100 countries and regions abroad.

Biolite has established seven industrial bases in guangdong, jiangsu, jiangxi, hubei, liaoning, chongqing and tianjin, and initially completed the national strategic layout. Implementing the international strategy of Go out and Bring it back, the company has prepared the blood purification industry infrastructure in Germany. This facility introduces advanced management, experience and technology from Germany or Europe in the blood purification field, promoting the localization of hemodialysis equipment and consumables, and improving the quality, control and efficiency of the company.